Alloy Therapeutics Inc. ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

Salesforce (CRM) announced that Takeda has selected Salesforce Life Sciences Cloud for Customer Engagement to strengthen its ...

Naoe will remark that the estate with the diamond flags belongs to Takeda. When the woman stops, head through the archway straight ahead. You’ll be told to follow the sound of the shamisen. Look right ...

Those data centers that are equipped to handle AI processing loads are projected to require $5.2 trillion in capital ...

Dan Gandor, an omnichannel ace who has spent his entire career on the client side of the business, has joined Eversana ...

Salesforce (NYSE:CRM) announced a significant partnership with Takeda, selecting its Life Sciences Cloud for customer ...

Takeda has shot down candidates acquired in its $525 million Maverick Therapeutics takeover, blowing a hole in its oncology R ...

No-moat Takeda Pharmaceutical is Japan’s leading pharmaceutical company by revenue. While the firm historically focused on the Japan market, management has undertaken an ambitious overhaul to ...

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

Takeda was scrambling to accommodate for rapidly sinking profits from the hasty decline of ADHD mainstay Vyvanse with a 140 ...

Christophe Weber, CEO of Takeda Pharma, discusses the group's plans to invest $30 billion into its U.S. operations over the ...